CDx Diagnostics: Novel AI-powered laboratory test for diagnosis of Barrett's esophagus, with or without dysplasia SUFFERN, N.Y., July 24, 2025 (Newswire.com) – CDx Diagnostics announced today that the U.S. Food and Drug Administration...

CDx Diagnostics: New Research Shows Progression to Esophageal Cancer as Detected by WATS3D SUFFERN, NY (February 22, 2022) — A newly published study as lead article in Gastrointestinal Endoscopy shows that Barrett’s esophagus (BE) and...

CU Cancer Center member Sachin Wani, MD, is leading a study to test the effectiveness of a novel diagnostic tool to improve detection of early esophageal cancer. On a mission to increase early detection of esophageal cancer, University of...

Diagnosing pathological cancer is often a challenge, even for the most skilled clinicians. Many forms of cancer do not exhibit noticeable symptoms until the infection has progressed too far to treat effectively. Monoclonal antibodies are...

With almost 1 million new cases per year, gastric cancer is currently the number four most common malignant disease. Today, there is no universal standard treatment. Recently, however, the ToGA trial demonstrated efficacy of Trastuzumab...